Increased circulating cytokines in patients with myocarditis and cardiomyopathy. - Wikidata - wikimedia - TriplyDB

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

http://www.wikidata.org/entity/Q33614427

about

A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design The physiology of cardiovascular disease and innovative liposomal platforms for therapy A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling Sarcopenia in heart failure: mechanisms and therapeutic strategies ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes Endothelial dysfunction: a comprehensive appraisal.Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials.Protective effect of resveratrol against pressure overload-induced heart failure.It is time to ask what adenosine can do for cardioprotection.Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.Mao-to Prolongs the Survival of and Reduces TNF-alpha Expression in Mice with Viral Myocarditis.Activation of cytokines as a mechanism of disease progression in heart failure A glossary of circulating cytokines in chronic heart failure.Role of cytokines in autoimmune myocarditis and cardiomyopathy.The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice.Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?Inflammatory mediators in chronic heart failure: an overview Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy Role of the innate immune system in acute viral myocarditis.Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.Future prospects of anticytokine therapy in chronic heart failure.Agents targeting inflammation in heart failure.Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis Ameliorated stress related proteins are associated with improved cardiac function by sarcoplasmic reticulum calcium ATPase gene transfer in heart failure.Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin.Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives.Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.Tumor necrosis factor-alpha and mortality in heart failure: a community study.Diagnosis and treatment of viral myocarditis.Overview of emerging pharmacotherapy in chronic heart failure.gp130-mediated pathway and heart failure.Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

P2860

Q24647087-21A75E4F-844D-4FC4-96F5-A7A21AA78FC3 Q27002949-974CF79E-C6D2-49E7-9187-B6E0E02E9517 Q27316099-CBD1C114-5ED7-4038-B42B-FD303BDE3FE3 Q28066237-BD0C4C03-032F-46BF-85B1-E3EF2B375ACE Q28180984-8840A64E-D13C-4EA6-9A0F-AD748C8B86C9 Q28195411-A5DE3DDF-44C9-48C8-9A6A-F7CF453AF123 Q28570331-B6780896-2546-489D-8C56-24AB7603BA17 Q30414170-E47D2973-70B7-4FDB-987E-C3DFB893A6A8 Q31096498-499AAD7D-9BD7-437F-83FE-BD2ABAEF6239 Q33723046-D3A0AC1E-E372-4CC2-977C-B2C0FD7EF35F Q33731467-2107421E-9BB4-46F8-9316-268357896B20 Q33863961-9CBFF9C5-3BB9-4402-8168-152E955D4CE4 Q33919739-144AFE43-E10F-40C8-A743-92DAFC888316 Q34071319-66324F21-A047-4B62-9AE1-CECE70363CB9 Q34398220-8EE0EDED-5C2E-4B87-B368-D7F8780AEAA4 Q34574052-62CD48B3-0580-4070-94E5-EC949E194CB0 Q34793636-A1C73FE5-5583-4A64-AFA9-11807F20B560 Q34981029-5F1D193D-39E9-4330-AA92-7C0D51D9C70E Q35083462-68DAF67B-B9E2-4C2B-9EFE-9FF65ED3374B Q35103414-C8FA2111-4C69-4AA2-8FED-153E7E3CF2DC Q35467456-9A31EBD7-CD91-48B4-8235-FE64E72F205D Q35579705-5AC02D6A-D0E1-46AA-8488-39398CA405B6 Q35582235-778608EC-C416-47A2-8435-B0F45BE1563B Q35764592-6164EB0B-88DA-45C5-BB56-4B31423D924B Q35971582-1C637C2F-6F13-4F19-A532-AE81F094B360 Q36011990-0083D11C-8BB6-41FD-8F5E-4137F636E0BA Q36086324-2C155F03-1711-403E-ADBA-3EEC504A4C69 Q36087238-38F068A1-B372-4848-90EA-25FD0CCE3E89 Q36145827-B22576DE-B65D-476F-813A-8E5013845EDF Q36204135-E4C8C609-E952-45F9-914E-5E5EA58FCC91 Q36313661-24DDAE4A-158B-4A7D-8673-9D0143B7B409 Q36591937-1B3940FD-602F-4E40-B68F-31053F66A011 Q36616874-41FF5B32-8832-4374-B484-9CB3DFFE5246 Q36829997-CC6018CF-000A-4B75-BEA0-786D4B5706D9 Q36833376-81C8DF99-DCAE-4B94-BC4E-F899F083D52C Q37192858-6A54E9EC-4621-42EE-8D5B-569F1E2275BA Q37406711-9A682A85-8C5C-41DE-AD37-AE9AF675998E Q37552943-00B6D9B7-776D-498F-82C1-90EE5C6A3793 Q37608600-76DE78F3-FF54-4F01-92EF-284A3E0EB7C0 Q37810952-8D1DD35F-BF1D-4425-B9A0-78E1D7C225AF

P2860

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

http://www.wikidata.org/entity/Q33614427

description

1994 nî lūn-bûn

@nan

1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@ast

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@en

type

label

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@ast

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@en

prefLabel

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@ast

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@en

P1433

Q33614427-2D6F338F-613F-429A-BCF5-D69A11FFFEE6

P1476

Q33614427-4D985247-8FDD-4C95-A8B2-B1D96C9B9F97

P2093

Q33614427-04151DCB-C2B8-4DFE-8803-27DDF329328C

Q33614427-739C39AD-968F-427D-8DF8-9F26604710F5

Q33614427-89A781E4-EFDE-4D94-86CF-A686736BFDD2

Q33614427-D2661F77-EBDD-4911-AA08-C233FA13895D

Q33614427-E293879B-C6CA-4A76-BC3D-BE0CB3C98B15

P2860

Q33614427-00C687B7-1ADB-4DDB-868E-BFF4927172B2

Q33614427-04FA71BE-4C74-4709-AAE4-4A6D365547D0

Q33614427-076E0838-59A4-4786-B9F0-222E55AEFBB9

Q33614427-11033FE5-65FB-4376-934F-64922E7CFFBF

Q33614427-3541214C-BDE1-43C6-A398-12CDD50575D0

Q33614427-39B06AC0-4086-4C73-B878-427AF4D8FA36

Q33614427-3B984903-0493-439F-A776-1AA0D5DA00E0

Q33614427-43823DAD-D587-4698-9A42-E0EFA2D4F202

Q33614427-4438506C-F945-45A8-AC55-9AEEF597F121

Q33614427-4834504A-4650-4A9D-AD8C-9337C7BE05C8

P304

Q33614427-CC7F0B25-43DD-46CC-BF24-3C5FA3283E7F

P31

Q33614427-B66BD2E0-4CA4-4601-B0B2-A7F2B631987F

P356

Q33614427-246CF881-A989-4640-93E6-DE15D9601E53

P433

Q33614427-B65CF2FB-A412-460F-9389-4C1975D5C599

P478

Q33614427-E6B3CF80-B2AF-457C-A748-C4B984DB4414

P577

Q33614427-0109BB2B-39AB-4CDE-BB2B-E2EC00DC9FDC

P5875

Q33614427-A317CBD7-F917-4AF9-9A1D-9EA45E705E0E

P698

Q33614427-64FF1365-D3B6-4F9A-BC2B-ECBA70015BE4

P932

Q33614427-3CF7CCBA-F0DB-4198-84FF-75E283C32B5F

P356

P1433

British heart journal

P1476

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

@en

P2093

Matoba Y

http://www.w3.org/2001/XMLSchema#string

Matsumori A

http://www.w3.org/2001/XMLSchema#string

Sasayama S

http://www.w3.org/2001/XMLSchema#string

Suzuki H

http://www.w3.org/2001/XMLSchema#string

Yamada T

http://www.w3.org/2001/XMLSchema#string

P2860

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy--clinical and experimental data.

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.

Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice.

Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential

How many genes code for organ-specific autoimmunity?

Interleukin-1 and its receptor.

Molecular biology and genetics of interleukin-1.

P304

561-566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.72.6.561

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

1994-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15340968

http://www.w3.org/2001/XMLSchema#string

P698

7857740

http://www.w3.org/2001/XMLSchema#string

P932

1025643

http://www.w3.org/2001/XMLSchema#string